These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 34228538)

  • 21. Multidrug-resistant Klebsiella pneumoniae harboring extended spectrum β-lactamase encoding genes isolated from human septicemias.
    Carvalho I; Chenouf NS; Carvalho JA; Castro AP; Silva V; Capita R; Alonso-Calleja C; Enes Dapkevicius MLN; Igrejas G; Torres C; Poeta P
    PLoS One; 2021; 16(5):e0250525. PubMed ID: 33945553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization and comprehensive genome analysis of novel bacteriophage, vB_Kpn_ZCKp20p, with lytic and anti-biofilm potential against clinical multidrug-resistant
    Zaki BM; Fahmy NA; Aziz RK; Samir R; El-Shibiny A
    Front Cell Infect Microbiol; 2023; 13():1077995. PubMed ID: 36756618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of a New Variant OXA-204 and OXA-48 Carbapenemases Plasmids Encoded in Klebsiella pneumoniae Clinical Isolates in Tunisia.
    Ouertani R; Ben Jomàa-Jemili M; Gharsa H; Limelette A; Guillard T; Brasme L; de Champs C; Chouchani C
    Microb Drug Resist; 2018 Mar; 24(2):142-149. PubMed ID: 28737463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
    Kuzucu C; Yetkin F; Görgeç S; Ersoy Y
    Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
    Pichardo C; del Carmen Conejo M; Bernabéu-Wittel M; Pascual A; Jiménez-Mejías ME; de Cueto M; Pachón-Ibáñez ME; García I; Pachón J; Martínez-Martínez L
    Clin Microbiol Infect; 2005 Jan; 11(1):31-8. PubMed ID: 15649301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein.
    Bradford PA; Urban C; Mariano N; Projan SJ; Rahal JJ; Bush K
    Antimicrob Agents Chemother; 1997 Mar; 41(3):563-9. PubMed ID: 9055993
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Stewart AG; Cottrell K; Henderson A; Vemuri K; Bauer MJ; Paterson DL; Harris PNA
    Microbiol Spectr; 2021 Sep; 9(1):e0022621. PubMed ID: 34232101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time-kill synergy tests of tigecycline combined with imipenem, amikacin, and ciprofloxacin against clinical isolates of multidrug-resistant Klebsiella pneumoniae and Escherichia coli.
    Yim H; Woo H; Song W; Park MJ; Kim HS; Lee KM; Hur J; Park MS
    Ann Clin Lab Sci; 2011; 41(1):39-43. PubMed ID: 21325253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multicenter study of β-lactamase-producing Klebsiella pneumoniae isolated from university teaching hospitals of Urmia, Iran.
    Darabi N; Motazakker M; Khalkhali HR; Yousefi S
    J Infect Dev Ctries; 2019 Aug; 13(8):690-697. PubMed ID: 32069252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined porin loss and extended spectrum beta-lactamase production is associated with an increasing imipenem minimal inhibitory concentration in clinical Klebsiella pneumoniae strains.
    Yang D; Guo Y; Zhang Z
    Curr Microbiol; 2009 Apr; 58(4):366-70. PubMed ID: 19219497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of imipenem/relebactam against Gram-negative ESKAPE pathogens isolated in 17 European countries: 2015 SMART surveillance programme.
    Karlowsky JA; Lob SH; Kazmierczak KM; Hawser SP; Magnet S; Young K; Motyl MR; Sahm DF
    J Antimicrob Chemother; 2018 Jul; 73(7):1872-1879. PubMed ID: 29659861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of Environmental
    Weber-Dąbrowska B; Żaczek M; Łobocka M; Łusiak-Szelachowska M; Owczarek B; Orwat F; Łodej N; Skaradzińska A; Łaczmański Ł; Martynowski D; Kaszowska M; Górski A
    Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of β-lactamase genes among carbapenem-resistant Klebsiella pneumoniae strains isolated from patients in Turkey.
    Iraz M; Özad Düzgün A; Sandallı C; Doymaz MZ; Akkoyunlu Y; Saral A; Peleg AY; Özgümüş OB; Beriş FŞ; Karaoğlu H; Çopur Çiçek A
    Ann Lab Med; 2015 Nov; 35(6):595-601. PubMed ID: 26354347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First Clinical Cases of KPC-2-Producing
    Brahmia S; Lalaoui R; Nedjai S; Djahmi N; Chettibi S; Rolain JM; Bakour S
    Microb Drug Resist; 2021 May; 27(5):652-659. PubMed ID: 32991248
    [No Abstract]   [Full Text] [Related]  

  • 35. Characterization and genome analysis of novel Klebsiella phage BUCT556A with lytic activity against carbapenemase-producing Klebsiella pneumoniae.
    Feng J; Gao L; Li L; Zhang Z; Wu C; Li F; Tong Y
    Virus Res; 2021 Oct; 303():198506. PubMed ID: 34271040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Investigation of carbapenemases in carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains isolated in 2014 in Turkey].
    Çakar A; Akyön Y; Gür D; Karatuna O; Öğünç D; Özhak Baysan B; Çöplü N; Çağatay M; Kılıç A; Baysallar M; Bakıcı Z; Çelik C; Gülay Z; Aydemir Ş; Tünger A; Kılıç H; Erçal BD; Aşçı Toraman Z; Zer Y; Büyüktaş A; Ay S; Aktaş Z; Kayacan Ç; Bayramoğlu G; Aydın F; Dündar D; Hasdemir U; Ayaş R; Yanık K; Günaydın M; Güdücüoğlu H; Parlak M
    Mikrobiyol Bul; 2016 Jan; 50(1):21-33. PubMed ID: 27058326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo activities of a novel β-lactamase inhibitor combination imipenem/XNW4107 against recent clinical Gram-negative bacilli from China.
    Li Y; Yan M; Xue F; Zhong W; Liu X; Chen X; Wu Y; Zhang J; Wang Q; Zheng B; Lv Y
    J Glob Antimicrob Resist; 2022 Dec; 31():1-9. PubMed ID: 35820591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of OXA-1 β-lactamase gene of Klebsiella pneumoniae from blood stream infections (BSI) by conventional PCR and in-silico analysis to understand the mechanism of OXA mediated resistance.
    Sugumar M; Kumar KM; Manoharan A; Anbarasu A; Ramaiah S
    PLoS One; 2014; 9(3):e91800. PubMed ID: 24647004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The emergence of OXA-48- and NDM-1-positive Klebsiella pneumoniae in Riyadh, Saudi Arabia.
    Shibl A; Al-Agamy M; Memish Z; Senok A; Khader SA; Assiri A
    Int J Infect Dis; 2013 Dec; 17(12):e1130-3. PubMed ID: 24021566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First description of antimicrobial resistance in carbapenem-susceptible Klebsiella pneumoniae after imipenem treatment, driven by outer membrane remodeling.
    Tian X; Wang Q; Perlaza-Jiménez L; Zheng X; Zhao Y; Dhanasekaran V; Fang R; Li J; Wang C; Liu H; Lithgow T; Cao J; Zhou T
    BMC Microbiol; 2020 Jul; 20(1):218. PubMed ID: 32689945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.